To test whether adult committed neural progenitors and adult OPCs can give rise to gliomas, a well-designed study leveraged the Ascl1-creERTM transgenic mouse line to target Nf1, Trp53 and Pten loss-of -function mutations specifically in these cells to the exclusion of neural stem cells [50]. This evidence concerns the gene NF1 and central nervous system cancer.